US6258578B1ExpiredUtility
His5
Est. expiryAug 11, 2017(expired)· nominal 20-yr term from priority
Inventors:Sanjoy BiswasMartin Karl Russel BurnhamMichael Arthur LonettoPatrick Vernon WarrenRichard Lloyd Warren
A61P 5/00A61P 43/00A61P 27/16A61P 27/00A61P 31/04A61P 27/02A61P 25/00A61P 31/00A61P 1/00C12N 9/1096A61P 13/02A61P 1/12A61P 13/12A61P 19/02A61P 11/04A61P 11/00A61P 17/00A61P 19/00A61K 38/00A61P 13/00C12N 9/78A61P 19/08A61K 39/00
35
PatentIndex Score
1
Cited by
12
References
22
Claims
Abstract
The invention provides HIS5 polypeptides and DNA (RNA) encoding HIS5 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing HIS5 polypeptides to screen for antibacterial compounds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. An isolated polynucleotide segment, comprising a first polynucleotide sequence, or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence encodes the same polypeptide, expressed by the HIS5 gene encoded by a nucleic acid sequence comprising SEQ ID NO:1 contained in Staphylococcus aureus WCUH 29 contained in NCIMB Deposit No. 40771.
2. The isolated polynucleotide segment of claim 1 encoding fusion polypeptide wherein the first polynucleotide sequence encodes part of the fusion polypeptide.
3. An isolated polynucleotide segment, comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence hybridizes to the full complement of SEQ ID NO:1, wherein the hybridization conditions include incubation at 42° C. in a solution comprising: 50% formamide, 5×SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH7.6), 5×Denhardt's solution, 10% dextran sulfate, and 20 micrograms/ml denatured, sheared salmon sperm DNA, followed by washing in 0.1×SSC at about 65° C.; and wherein the first polynucleotide sequence is identical to SEQ ID NO:1 except that, over the entire length corresponding to SEQ ID NO:1, there are up to five point mutations for every 100 nucleotides of SEQ ID NO:1, wherein each point mutation is the substitution, deletion or insertion of one nucleotide; and wherein the first polynucleotide sequence detects Staphylococcus aureus.
4. The isolated polynucleotide segment of claim 3 , wherein the first polynucleotide sequence hybridizes to the full complement of SEQ ID NO:1, wherein the hybridization conditions include incubation at 42° C. in a solution comprising: 50% formamide, 5×SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH7.6), 5×Denhardt's solution, 10% dextran sulfate, and 20 micrograms/ml denatured, sheared salmon sperm DNA, followed by washing in 0.1×SSC at about 65° C.; and wherein the first polynucleotide sequence is identical to SEQ ID NO:1 except that, over the entire length corresponding to SEQ ID NO:1, there are up to three point mutations for every 100 nucleotides of SEQ ID NO:1, wherein each point mutation is the substitution, deletion or insertion of one nucleotide.
5. An isolated polynucleotide segment comprising, a first polynucleotide sequence, wherein the first polynucleotide sequence encodes a polypeptide comprising the amino acid sequence as set forth in SEQ ID NO:2.
6. A vector comprising the isolated polynucleotide segment of claim 5 .
7. An isolated host cell comprising the vector of claim 6 .
8. A process for producing a polypeptide, comprising culturing the host cell of claim 7 under conditions sufficient for the production of the polypeptide.
9. The isolated polynucleotide segment of claim 5 , wherein the first polynucleotide sequence encodes a polypeptide consisting of the amino acid sequence as set forth in SEQ ID NO:2.
10. A vector comprising the isolated polynucleotide segment of claim 9 .
11. An isolated host cell comprising the vector of claim 10 .
12. A process for producing a polypeptide, comprising culturing the host cell of claim 11 under conditions sufficient for the production of the polypeptide.
13. An isolated polynucleotide of the formula:
X—(R 1 ) n —(SEQ ID NO:1)—(R 2 ) n —Y
wherein, at the 5′ end of the molecule, X is hydrogen, and at the 3′ end of the molecule, Y is hydrogen or a metal, R 1 and R 2 is any nucleic acid residue, and n is an integer between 1 and 1000.
14. An isolated polynucleotide segment comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence wherein the first polynucleotide sequence is selected from the group consisting of
(a) a polynucleotide comprising the nucleotide sequence as set forth in SEQ ID NO:1; and
(b) a nucleic acid sequence identical to the polynucleotide of (a) except that, over the entire length corresponding to the polynucleotide of (a), there are up to five point mutations for every 100 nucleotides of the polynucleotide of (a), wherein each point mutation is the substitution, deletion or insertion of one nucleotide
; and wherein the first polynucleotide sequence detects Staphylococcus aureus.
15. A vector comprising the isolated polynucleotide segment of claim 14 .
16. An isolated host cell comprising the vector of claim 15 .
17. The isolated polynucleotide segment of claim 16 , wherein the first polynucleotide sequence is a nucleic acid sequence identical to the polynucleotide of (a) except that, over the entire length corresponding to the polynucleotide of (a), wherein each point mutation is the substitution, deletion or insertion of one nucleotide.
18. An isolated polynucleotide segment comprising a first polynucleotide sequence or the full complement of the entire length of the first polynucleotide sequence, wherein the first polynucleotide sequence comprises SEQ ID NO:1.
19. A vector comprising the isolated polynucleotide segment of claim 18 .
20. An isolated host cell comprising the vector of claim 19 .
21. A process for producing a polypeptide comprising culturing the host cell of claim 20 under conditions sufficient for the production of the polypeptide, wherein the isolated polynucleotide segment comprises the first polynucleotide sequence.
22. The isolated polynucleotide segment of claim 18 encoding a fusion polypeptide wherein the first polynucleotide sequence encodes part of the fusion polypeptide.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.